Burkhard-Meier, Anton https://orcid.org/0009-0002-9801-3530
Grube, Matthias
Jurinovic, Vindi
Agaimy, Abbas
Albertsmeier, Markus
Berclaz, Luc M.
Di Gioia, Dorit
Dürr, Hans Roland
von Eisenhart-Rothe, Rüdiger
Eze, Chukwuka
Fechner, Katja
Fey, Emma
Güler, Sinan E.
Hecker, Judith S.
Hendricks, Anne
Keil, Felix
Klein, Alexander
Knebel, Carolin
Kovács, Julia R.
Kunz, Wolfgang G.
Lenze, Ulrich
Lörsch, Alisa M.
Lutz, Mathias
Meidenbauer, Norbert
Mogler, Carolin
Schmid, Sebastian
Schmidt-Hegemann, Nina-Sophie
Schneider, Christian
Semrau, Sabine
Sienel, Wulf
Trepel, Martin
Waldschmidt, Johannes
Wiegering, Armin
Lindner, Lars H.
Funding for this research was provided by:
Bavarian Cancer Research Center
Klinikum der Universität München
Article History
Received: 27 February 2025
Accepted: 23 April 2025
First Online: 14 May 2025
Disclosure
: Johannes Waldschmidt is on the advisory board for Pharmamar.